Aicher; Thomas D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aicher; Thomas D..The latest application filed is for "indolinyl sulfonamide and related compounds for use as agonists of rory and the treatment of disease".

Company Profile

13.32.32

Aicher; Thomas D. - Ann Arbor MI
Aicher; Thomas D. - Boulder CO
Aicher; Thomas D. - Superior CO US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Grant 10,745,364 - Aicher , et al. A	2020-08-18
Indolinyl Sulfonamide And Related Compounds For Use As Agonists Of Rory And The Treatment Of Disease App 20200207726 - VanHuis; Chad A. ; et al.	2020-07-02
Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease Grant 10,556,898 - Aicher , et al. Feb	2020-02-11
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods Grant 10,532,088 - Glick , et al. Ja	2020-01-14
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of ROR.gamma. and the treatment of disease Grant 10,442,798 - Aicher , et al. Oc	2019-10-15
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE App 20190292159 - Aicher; Thomas D. ; et al.	2019-09-26
Indazolyl-1,2,4-thiadiazolamines And Related Compounds For Inhibition Of Rho-associated Protein Kinase And The Treatment Of Dise App 20190276447 - Aicher; Thomas D. ; et al.	2019-09-12
N-substituted pyrazolyl guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof Grant 10,392,350 - Aicher , et al. A	2019-08-27
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Grant 10,377,768 - Aicher , et al. A	2019-08-13
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of ROR.gamma. and the treatment of disease Grant 10,364,237 - Aicher , et al.	2019-07-30
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Grant 10,221,146 - Aicher , et al.	2019-03-05
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ROR.gamma. and the treatment of disease Grant 10,208,061 - Aicher , et al. Feb	2019-02-19
Benzenesulfonamido and related compounds for use as agonists of ROR.gamma. and the treatment of disease Grant 10,189,777 - Aicher , et al. Ja	2019-01-29
Mitotic Kinesin Inhibitors And Methods Of Use Thereof App 20180334441 - Hans; Jeremy ; et al.	2018-11-22
TETRAHYDROQUINOLINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE App 20180265502 - Aicher; Thomas D. ; et al.	2018-09-20
N-substituted Pyrazolyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof App 20180222867 - Aicher; Thomas D. ; et al.	2018-08-09
TETRAHYDROQUINOLINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE App 20180208587 - Aicher; Thomas D. ; et al.	2018-07-26
Tetrahydro[1,8]naphthyridine Sulfonamide And Related Compounds for Use as Agonists of RORy and the Treatment of Disease App 20180179224 - Aicher; Thomas D. ; et al.	2018-06-28
N-substituted pyrazolyl guanidine F.sub.1F.sub.0-ATPase inhibitors and therapeutic uses thereof Grant 9,914,706 - Aicher , et al. March 13, 2	2018-03-13
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of ROR.gamma. and the treatment of disease Grant 9,896,441 - Aicher , et al. February 20, 2	2018-02-20
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20180030005 - Aicher; Thomas D. ; et al.	2018-02-01
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Grant 9,809,561 - Aicher , et al. November 7, 2	2017-11-07
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20170313722 - Aicher; Thomas D. ; et al.	2017-11-02
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease Grant 9,802,958 - Aicher , et al. October 31, 2	2017-10-31
Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Grant 9,783,511 - Aicher , et al. October 10, 2	2017-10-10
BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE App 20170190659 - Aicher; Thomas D. ; et al.	2017-07-06
TETRAHYDROQUINOLINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE App 20170183331 - Aicher; Thomas D. ; et al.	2017-06-29
2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Grant 9,663,502 - Aicher , et al. May 30, 2	2017-05-30
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of ROR.gamma. activity and the treatment of disease Grant 9,657,033 - Aicher , et al. May 23, 2	2017-05-23
Mitotic Kinesin Inhibitors And Methods Of Use Thereof App 20170066733 - Hans; Jeremy ; et al.	2017-03-09
Adoptive Cellular Therapy Using an Agonist of Retinoic Acid Receptor-Related Orphan Receptor Gamma & Related Therapeutic Methods App 20170007686 - Glick; Gary D. ; et al.	2017-01-12
N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of ROR.gamma. activity and the treatment of disease Grant 9,512,111 - Glick , et al. December 6, 2	2016-12-06
Mitotic kinesin inhibitors and methods of use thereof Grant 9,499,503 - Hans , et al. November 22, 2	2016-11-22
Tetrahydro[1,8]naphthyridine Sulfonamide And Related Compounds for Use as Agonists of RORy and the Treatment of Disease App 20160318951 - Aicher; Thomas D. ; et al.	2016-11-03
CARBAMATE BENZOXAZINE PROPIONIC ACIDS AND ACID DERIVATIVES FOR MODULATION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20160311787 - Aicher; Thomas D. ; et al.	2016-10-27
2-ACYLAMIDOMETHYL AND SULFONYLAMIDOMETHYL BENZOXAZINE CARBAMATES FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20160304505 - Aicher; Thomas D. ; et al.	2016-10-20
TETRAHYDRONAPHTHYRIDINE, BENZOXAZINE, AZA-BENZOXAZINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20160304476 - Aicher; Thomas D. ; et al.	2016-10-20
N-substituted Pyrazolyl Guanidine F1f0-atpase Inhibitors And Therapeutic Uses Thereof App 20160304464 - Aicher; Thomas D. ; et al.	2016-10-20
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of ROR.gamma. and the treatment of disease Grant 9,394,315 - Aicher , et al. July 19, 2	2016-07-19
Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease Grant 9,266,827 - Aicher , et al. February 23, 2	2016-02-23
Mitotic kinesin inhibitors and methods of use thereof Grant 9,102,639 - Hans , et al. August 11, 2	2015-08-11
Mitotic Kinesin Inhibitors And Methods Of Use Thereof App 20150210658 - Hans; Jeremy ; et al.	2015-07-30
Tetrahydro[1,8]naphthyridine Sulfonamide and Related Compounds for Use as Agonists of RORy and the Treatment of Disease App 20150133437 - Aicher; Thomas D. ; et al.	2015-05-14
BICYCLIC SULFONE COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20150126493 - Aicher; Thomas D. ; et al.	2015-05-07
TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE App 20150111877 - Aicher; Thomas D. ; et al.	2015-04-23
Glucokinase activators Grant 8,933,077 - Aicher , et al. January 13, 2	2015-01-13
Mitotic Kinesin Inhibitors And Methods Of Use Thereof App 20140094603 - Hans; Jeremy ; et al.	2014-04-03
Mitotic kinesin inhibitors and methods of use thereof Grant 8,623,895 - Hans , et al. January 7, 2	2014-01-07
Mitotic Kinesin Inhibitors and Methods of Use Thereof App 20120270803 - Hans; Jeremy ; et al.	2012-10-25
Mitotic kinesin inhibitors and methods of use thereof Grant 8,236,825 - Hans , et al. August 7, 2	2012-08-07
2-aminopyridine Analogs As Glucokinase Activators App 20110281874 - AICHER; Thomas D. ; et al.	2011-11-17
Glucokinase activators Grant 8,022,222 - Aicher , et al. September 20, 2	2011-09-20
2-aminopyridine analogs as glucokinase activators Grant 8,022,223 - Aicher , et al. September 20, 2	2011-09-20
Mitotic Kinesin Inhibitors And Methods Of Use Thereof App 20110201651 - Hans; Jeremy ; et al.	2011-08-18
Mitotic kinesin inhibitors and methods of use thereof Grant 7,956,073 - Hans , et al. June 7, 2	2011-06-07
Glucokinase Activators App 20100056530 - Aicher; Thomas D. ; et al.	2010-03-04
Glucokinase Activators App 20090247526 - Aicher; Thomas D. ; et al.	2009-10-01
2-aminopyridine Analogs As Glucokinase Activators App 20090156603 - Aicher; Thomas D. ; et al.	2009-06-18
Mitotic kinesin inhibitors and methods of use thereof Grant 7,449,486 - Hans , et al. November 11, 2	2008-11-11
Mitotic Kinesin Inhibitors and Methods of Use Thereof App 20080182992 - Hans; Jeremy ; et al.	2008-07-31
Mitotic kinesin inhibitors and methods of use thereof App 20060100161 - Hans; Jeremy ; et al.	2006-05-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.